Arizona State Retirement System - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 130 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Arizona State Retirement System ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$505,706
-18.7%
10,996
+1.5%
0.00%
-20.0%
Q2 2023$622,343
+48.1%
10,829
-3.3%
0.01%
+25.0%
Q1 2023$420,113
+35.5%
11,203
+1.3%
0.00%
+33.3%
Q4 2022$310,013
+4.0%
11,064
+4.2%
0.00%0.0%
Q3 2022$298,000
-17.5%
10,616
+2.3%
0.00%
-25.0%
Q2 2022$361,000
-2.7%
10,374
+0.3%
0.00%
+33.3%
Q1 2022$371,000
+53.9%
10,347
+0.0%
0.00%
+50.0%
Q4 2021$241,000
+22.3%
10,342
-0.4%
0.00%0.0%
Q3 2021$197,000
-5.3%
10,380
+0.5%
0.00%0.0%
Q2 2021$208,000
+2.5%
10,330
-6.6%
0.00%0.0%
Q1 2021$203,000
-8.6%
11,063
+0.4%
0.00%0.0%
Q4 2020$222,000
+6.2%
11,016
-1.2%
0.00%0.0%
Q3 2020$209,000
-52.6%
11,152
-51.2%
0.00%
-60.0%
Q4 2019$441,000
-45.1%
22,849
-43.6%
0.01%
-50.0%
Q3 2019$803,000
-30.5%
40,490
-26.1%
0.01%
-23.1%
Q2 2019$1,156,000
+6.1%
54,756
+2.7%
0.01%0.0%
Q1 2019$1,090,000
+2.8%
53,334
+0.2%
0.01%
-7.1%
Q4 2018$1,060,000
+9.5%
53,243
+5.8%
0.01%
+55.6%
Q3 2018$968,000
+21.5%
50,325
-3.6%
0.01%
+12.5%
Q2 2018$797,000
-24.0%
52,222
-6.6%
0.01%
-27.3%
Q1 2018$1,048,000
-8.5%
55,899
-6.1%
0.01%0.0%
Q4 2017$1,145,000
+245.9%
59,499
+221.6%
0.01%
+175.0%
Q3 2017$331,000
-0.3%
18,500
-0.5%
0.00%
-20.0%
Q2 2017$332,000
+22.5%
18,600
-0.5%
0.01%
+25.0%
Q1 2017$271,000
-20.5%
18,700
+1.1%
0.00%
-20.0%
Q4 2016$341,000
-2.3%
18,500
+0.5%
0.01%0.0%
Q3 2016$349,00018,4000.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$3,649,6053.75%
SHAKER INVESTMENTS LLC/OH 81,287$2,277,6621.41%
Mesirow Institutional Investment Management, Inc. 374,414$10,491,0801.38%
OBERWEIS ASSET MANAGEMENT INC/ 134,000$3,754,6800.80%
Portolan Capital Management 270,791$7,587,5640.75%
Hillsdale Investment Management Inc. 172,238$4,826,1090.41%
Capital Impact Advisors, LLC 14,669$411,0250.40%
Watershed Asset Management, L.L.C. 9,555$267,7310.34%
Quantedge Capital Pte Ltd 35,153$984,9870.33%
FEDERATED HERMES, INC. 3,284,217$92,023,7600.25%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders